Citigroup Upgrades Hims & Hers Health to Neutral, Raises Price Target to $24
Hims & Hers Health +13.72% Post
Hims & Hers Health HIMS | 24.29 25.70 | +13.72% +5.80% Post |
Citigroup analyst Daniel Grosslight upgrades Hims & Hers Health (NYSE:
HIMS) from Sell to Neutral and raises the price target from $13.25 to $24.
